C12N 9/0089
Acting on superoxide as acceptor
Official title: {acting on superoxide as acceptor (1.15)}
C12N9/0089 (Acting on superoxide as acceptor) appears on 276 US grants and 231 published applications in this corpus.
Search patents in C12N- Granted patents
- 276
- Published applications
- 231
- Assignees
- 205
- Inventors
- 700
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 5 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 16 | 0 |
| 1993 | 13 | 0 |
| 1994 | 11 | 0 |
| 1995 | 10 | 0 |
| 1996 | 10 | 0 |
| 1997 | 14 | 0 |
| 1998 | 23 | 0 |
| 1999 | 14 | 0 |
| 2000 | 18 | 0 |
| 2001 | 5 | 0 |
| 2002 | 7 | 11 |
| 2003 | 7 | 14 |
| 2004 | 3 | 4 |
| 2005 | 4 | 7 |
| 2006 | 6 | 3 |
| 2007 | 4 | 3 |
| 2008 | 4 | 7 |
| 2009 | 3 | 7 |
| 2010 | 3 | 11 |
| 2011 | 6 | 9 |
| 2012 | 3 | 8 |
| 2013 | 3 | 5 |
| 2014 | 4 | 10 |
| 2015 | 7 | 6 |
| 2016 | 5 | 15 |
| 2017 | 3 | 3 |
| 2018 | 3 | 10 |
| 2019 | 6 | 11 |
| 2020 | 9 | 10 |
| 2021 | 0 | 7 |
| 2022 | 7 | 14 |
| 2023 | 4 | 18 |
| 2024 | 3 | 14 |
| 2025 | 6 | 11 |
| 2026 | 3 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Tethering cysteine residues using cyclic disulfides18 Aug 2026US 12,709,745 B2Brandeis University
- Paramyxovirus virus-like particles as protein delivery vehicles14 Apr 2026US 12,600,956 B2The Penn State Research Foundation
- Macrocyclic modulators of disease associated protein misfolding and aggregation24 Feb 2026US 12,559,863 B2Resq Biotech
- Bacterial superoxide dismutases23 Sep 2025US 12,421,504 B2Novozymes A/S
- Acute respiratory distress syndrome therapeutic agent12 Aug 2025US 12,385,017 B2LTT Bio-Pharma Co., Ltd.
- Puffed grain fermented enzyme having superoxide dismutase activity and catalase activity, production method therefor, and food composition comprising same1 Oct 2026US 2026/0293943 A1EcoMarine, LLC
- Chemically-modified microorganism containing a superoxide dismutase mimic inorganic complex and use thereof for treating inflammatory diseases17 Sep 2026US 2026/0272998 A1
- Antibodies and ubiquitin ligase fusion proteins for misfolded superoxide dismutase-1 (sod1)13 Aug 2026US 2026/0232840 A1ProMIS Neurosciences Inc.
- Macrocyclic modulators of disease associated protein misfolding and aggregation6 Aug 2026US 2026/0226658 A1Resq Biotech
- Recombinant human albumin expression level improving method and cells and proteins16 Jul 2026US 2026/0201397 A1Tonghua Anrate Biopharmaceutical Co., Ltd
Most cited
By later US patents
- Expression using fused genes providing for protein product297US 4,751,180 AChiron Corporation · 1988
- Lyophilized polyethylene oxide modified protein and polypeptide complexes with cyclodextrin129US 5,529,915 ASterling Winthrop Inc. · 1996
- Eukaryotic regulatable transcription111US 4,876,197 AChiron Corporation · 1989
- Eukaryotic regulatable transcription110US 4,880,734 AChiron Corporation · 1989
- Compositions and methods for treatment and diagnosis of cardiovascular disease103US 6,124,433 AMillennium Pharmaceuticals, Inc. · 2000